0001062993-11-002527.txt : 20110609
0001062993-11-002527.hdr.sgml : 20110609
20110609060920
ACCESSION NUMBER: 0001062993-11-002527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110606
FILED AS OF DATE: 20110609
DATE AS OF CHANGE: 20110609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geller Matthew
CENTRAL INDEX KEY: 0001446201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 11902079
MAIL ADDRESS:
STREET 1: 248 CENTRAL PARK WEST
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0303
4
2011-06-06
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001446201
Geller Matthew
248 CENTRAL PARK WEST
NEW YORK
NY
10024
1
0
0
0
Common Stock, $0.001 par value
2011-06-06
4
S
0
5000
24.2270
D
5000
D
Common Stock, $0.001 par value
2011-06-07
4
S
0
5000
24.5741
D
0
D
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.10 to $24.38. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.52 to $24.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Matthew Geller by Carl A. Valenstein, attorney in fact
2011-06-08